Works matching IS 07302312 AND DT 2023 AND VI 124 AND IP 2
Results: 13
How statin drugs affect exosomes?
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 171, doi. 10.1002/jcb.30363
- By:
- Publication type:
- Article
Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 266, doi. 10.1002/jcb.30360
- By:
- Publication type:
- Article
Recent advance in mesenchymal stem cells therapy for atopic dermatitis.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 181, doi. 10.1002/jcb.30365
- By:
- Publication type:
- Article
Induced expression of miR‐1250‐5p exerts tumor suppressive role in triple‐negative breast cancer cells.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 282, doi. 10.1002/jcb.30362
- By:
- Publication type:
- Article
The epigenetic regulator BRD4 is required for myofibroblast differentiation of knee fibroblasts.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 320, doi. 10.1002/jcb.30368
- By:
- Publication type:
- Article
The role of S477N mutation in the molecular behavior of SARS‐CoV‐2 spike protein: An in‐silico perspective.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 308, doi. 10.1002/jcb.30367
- By:
- Publication type:
- Article
Inhibition of sPLA<sub>2</sub> enzyme activity by cell‐permeable antioxidant EUK‐8 and downregulation of p38, Akt, and p65 signals induced by sPLA<sub>2</sub> in inflammatory mouse paw edema model.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 294, doi. 10.1002/jcb.30366
- By:
- Publication type:
- Article
Effects of the pathological E200K mutation on human prion protein: A computational screening and molecular dynamics approach.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 254, doi. 10.1002/jcb.30359
- By:
- Publication type:
- Article
Discovery of octahydropyrrolo [3,2‐b] pyridin derivative as a highly selective Type I inhibitor of FGFR3 over VEGFR2 by high‐throughput virtual screening.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 221, doi. 10.1002/jcb.30357
- By:
- Publication type:
- Article
Differential gene expression analysis of RAGE‐S100A6 complex for target selection and the design of novel inhibitors for anticancer drug discovery.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 205, doi. 10.1002/jcb.30356
- By:
- Publication type:
- Article
An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 188, doi. 10.1002/jcb.30354
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 169, doi. 10.1002/jcb.30282
- Publication type:
- Article
IGF2BP2 enhances LincRNA01116 stability via m<sup>6</sup>A: A potential biomarker and therapeutic target for patients with pre‐eclampsia.
- Published in:
- Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 239, doi. 10.1002/jcb.30358
- By:
- Publication type:
- Article